Home › Articles › HRT Explained: What It Is, Who It's For, and What It Isn't

HRT Explained: What It Is, Who It's For, and What It Isn't

Editorial review · Updated 21 September 2026 · 9 min read

If the phrase "HRT" makes you picture a decades-old controversy rather than a modern, individualized treatment, you're not alone — a lot of the fear around it traces back to one widely misreported study from 2002. Here's where things actually stand today.

What HRT actually does

Menopausal hormone therapy can relieve vasomotor symptoms such as hot flashes and night sweats, and systemic estrogen is widely regarded as the most effective treatment for those symptoms. People with a uterus generally need endometrial protection with a progestogen when using systemic estrogen. The formulation and route depend on symptoms and individual risk factors.

The main types of HRT

HRT isn't one-size-fits-all. The main variables are which hormones are included, and how they're delivered:

Why this table is here: most articles say "HRT" as if it's one thing. In practice, the delivery method matters almost as much as the hormone itself. It changes both how it's used and its risk profile.

Who HRT is usually a good fit for

Major menopause guidance generally describes the benefit-risk balance of systemic hormone therapy as favourable for many healthy, symptomatic people who start treatment under age 60 or within about 10 years of menopause, but this is not a blanket eligibility rule. Personal history — including clotting, cardiovascular, cancer and liver risks — changes the decision and should be reviewed with a clinician.

Who should be more cautious, or needs a different conversation

HRT isn't automatically ruled out for everyone in these categories, but it does require a more careful conversation with a doctor: a personal history of breast cancer, certain other hormone-sensitive cancers, a history of blood clots or stroke, or active liver disease. This is exactly why HRT is an individualized decision rather than a blanket recommendation. The same treatment that is a clear net positive for one woman may carry more risk for another.

The controversy, briefly explained

Much of the lingering fear around HRT traces back to the Women's Health Initiative (WHI) study published in 2002, which initially suggested HRT significantly increased breast cancer and heart disease risk. Later re-analysis showed the original reporting overstated the risk for most women, particularly younger women starting HRT close to menopause. The group most commonly prescribed it today. Medical guidance has since been revised substantially, but the reputational damage from the initial (and often sensationalized) headlines has taken over two decades to unwind, and many women still carry outdated fear from that period.

Questions worth bringing to your doctor

A short list to make the conversation more productive:

• Given my personal and family health history, what's my individual risk profile?
• Which delivery method (patch, gel, tablet) would you recommend for me, and why?
• How long would you expect me to stay on it, and how will we review that over time?
• What symptoms should prompt me to check back in sooner than a routine follow-up?

Where HRT fits alongside routine and lifestyle

HRT treats the hormonal side of the transition, but it doesn't replace the value of a steady daily routine — sleep habits, movement, stress management and nutrition still matter, with or without HRT. That's the gap The Steady Method is built to fill: it's an educational structure for the routine side of things, alongside whatever medical treatment you and your doctor decide is right for you, not instead of it. If you're not sure whether what you're feeling is perimenopause or postmenopause, that context is also worth bringing to the appointment.

Related: frozen shoulder in menopause, where the HRT evidence is preliminary and frequently overstated.

Related: signs perimenopause is ending — why an FSH reading will not tell you where you are.